Skip to main content
WeightCited

DHEA لـ Abdominal Fat Reduction

C الأدلة أدلة محدودة من دراسات صغيرة، غير أن ثمة بعض الإشارات الإيجابية.

An 8-week RCT (n=45) found 7-Keto DHEA plus exercise produced greater weight loss (2.88 kg vs. 0.97 kg placebo). Meta-analysis in elderly found modest abdominal fat reduction. Long-term safety is unclear and DHEA is banned by WADA.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Ddhea\u0026condition\u003Dabdominal\u002Dfat'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

الخلاصة

An 8-week RCT (n=45) found 7-Keto DHEA plus exercise produced greater weight loss (2.88 kg vs. 0.97 kg placebo). Meta-analysis in elderly found modest abdominal fat reduction. Long-term safety is unclear and DHEA is banned by WADA.

Key Study Findings

Other n=60 7 weeks
Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing …
Dose: 200 mg/kg for 45 days مقابل: DHEA-induced PCOS model controls Outcome: PCOS attenuation via TLR4/MyD88/NF-kB pathway التأثير: BW p=0.025, testosterone p=0.005 <0.05 multiple endpoints

المجتمع المدروس: DHEA-induced PCOS C57BL/6J mice (4 groups, n=15)

In Vitro 3.0 weeks
Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
Dose: 4 g مقابل: Control Outcome: Gut microbiota composition التأثير: None None

المجتمع المدروس: None

Key Statistics

5

الدراسات

200

المشاركون

Positive

C

التقييم

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
25-50 mg/day DHEA
guidance:
Guided by serum DHEA-S levels
7ketodhea:
100 mg 2x/day

الحد الأعلى: 50 mg/day for general use; higher doses under medical supervision only

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
200 mg/kg for 45 days 7 weeks Positive 60
4 g 3.0 weeks Positive --

أفضل وقت للتناول: Morning (mimics natural diurnal pattern)

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Acne
  • Hair loss
  • Facial hair growth (women)
  • Mood changes
  • Hormonal side effects

التفاعلات المعروفة

  • Hormone-sensitive cancers (avoid)
  • Antiestrogens (may counteract)
  • Insulin and diabetes medications
  • WADA-banned in competitive sports

الحد الأقصى المسموح به: 50 mg/day for general use; higher doses under medical supervision only

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does DHEA help with Abdominal Fat Reduction?
Based on 5 studies with 200 participants, there is limited but promising evidence that DHEA may support Abdominal Fat Reduction management. Our evidence grade is C (Some Evidence).
How much DHEA should I take for Abdominal Fat Reduction?
Studies have used various dosages. A commonly studied range is 25-50 mg/day DHEA. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of DHEA?
Reported side effects may include Acne, Hair loss, Facial hair growth (women), Mood changes. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for DHEA and Abdominal Fat Reduction?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

References

  1. [1] Qin Yang et al.. Sci Rep. 2024. Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. doi:10.1038/s41598-024-81034-5 PubMed
  2. [2] Jing Xue et al.. Endocr J. 2019. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. doi:10.1507/endocrj.EJ18-0567 PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.